Frozen human T cells collected from a single health donor were activated with CD3/28 beads (ThermoFisher), expanded in vitro, thawed and electroporated with mRNA transcripts encoding c-Met BBZ CAR, mesothelin BBZ CAR and CD19 BBZ CAR as described [11 (link)]. We have previously demonstrated that the cytotoxic activity of mRNA c-Met-CAR T cells was specific against c-Met expressing cell lines such as M30, a human tumor cell line derived from mesothelioma [17 (link)] and cytotoxic activity was not observed against NCI-H522, a lung cancer cell line which lacks c-Met expression [16 (link)]. To confirm the cytolytic activity on c-Met expressing breast cancer cell lines, BT20 (ATCC HTB-19) and TB129 [14 (link)], tumor cells were loaded with 51Cr and incubated with mRNA electroporated CAR T cells (effector cells or E) at various E:T ratios in V-bottom plates for 4 hours. 51Cr released as a result of cell lysis was quantified as described [18 (link)]. All in vitro cell killing assays were performed in duplicates and repeated in at least three independent experiments.